Ophthalmic Drugs: World Market Prospects... ( NEW YORK May 2 2012 /- Reportlinker.c...)

Ophthalmic Drugs: World Market Prospects 2012-2022

Date:5/2/2012

NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Ophthalmic Drugs: World Market Prospects 2012-2022

http://www.reportlinker.com/p0847305/Ophthalmic-Drugs-World-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Report Details

How to find trends and revenue predictions for the ophthalmic drug industry

What are the commercial prospects for treating eye disorders? Visiongain's report shows you potential revenues to 2022 - data, forecasts and discussions.

This study investigates prescription drugs treating human eye diseases. It lets you assess forecasted sales trends at world market, therapeutic submarket, product and national level to 2022.

How will 20 leading ophthalmic drugs - including Lucentis, Visudyne, Xalatan/Xalacom and Restasis - perform from 2012? Our investigation gives you business research and analysis with sales forecasts.

You also see forecasting of five submarkets to 2022, finding potential revenues:

• Glaucoma treatments

• Anti-allergy, anti-inflammatory and anti-infective agents

• Retinal disorder treatments

• Dry eye treatments

• Other medicines.

Find coverage of the R&D pipeline too, by therapeutic area, assessing trends and outlooks.

What will happen next? The pharma industry will improve treatment of ocular disorders and increase revenues there. The R&D pipeline in ophthalmology is strong. Also, improved drug delivery and new formulations will be important.

Visiongain predicts that the world market for ocular drugs will grow strongly from 2012 to
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine technology :

1. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
2. Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
3. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
4. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
6. Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015
7. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
8. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
9. Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets
10. BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
11. French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec

Post Your Comments:

(Date:5/22/2013)... CLEVELAND , May 22, 2013 /PRNewswire/ ... Software,s enterprise content management (ECM) ... Meditech,s Hospital Information System . These organizations ... IT system and will use OnBase to ... corporate initiatives. (Logo: ...

(Date:5/22/2013)... 2013 Z-Medica, a leading developer and marketer ... first-ever line of products designed to meet the unique ... ® EMS 4x4 Dressing, QuikClot ® EMS ... Gauze™, all custom-designed to help responders stop bleeding fast ... to a hospital or trauma center. The line includes ...

(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...

Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2 Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3 Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6

[0] Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System [0] Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services [0] Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance

... Dec. 12 Nuvelo, Inc.,(Nasdaq: NUVO ) ... a Phase 2,proof-of-concept trial of alfimeprase for the ... been granted fast track designation by the U.S. ... indication. Fast,track designation, which was mandated by the ...

... N.C., Dec. 11 Chimerix, Inc., a,biotechnology company ... Company has initiated a multi-dose trial with its,lead ... infection. This,trial will study the pharmacokinetics and safety ... volunteers., "The high oral availability demonstrated by ...

Cached Medicine Technology:Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 2 Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 3 Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 4 Chimerix Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection 2

Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke Chimerix Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection

(Date:5/22/2013)... MD (PRWEB) May 22, 2013 According ... is an autoimmune disorder effecting up to 3 million ... causing damage to the small intestine and mal-absorption of ... such as diarrhea, constipation, weight loss and vitamin deficiency, ... diet. While there are many gluten-free foods that celiac ...

(Date:5/22/2013)... research shows that craving drugs such as nicotine ... brain that are implicated in determining the value ... Dr. Alain Dagher, from McGill University, suggests ... underlie addiction. These results were presented at the ... the Canadian Association for Neuroscience - Association Canadienne ...

(Date:5/22/2013)... (HealthDay News) -- Roughly four in 10 uninsured patients ... (COPD) actually do not have the lung disease, a ... were made based on an evaluation of symptoms, rather ... test known as spirometry, which shows how well a ... air they can exhale and how long that takes. ...

(Date:5/22/2013)... Mathews from the University of Melbourne said this small ... undoubted benefits from CT scans in diagnosing and monitoring ... British Medical Journal today and involved researchers ... the International Agency for Research on Cancer in Lyon, ... very useful in providing detailed three dimensional pictures to ...

(Date:5/22/2013)... King of Prussia, PA (PRWEB) May 22, 2013 ... is proud to announce its participation in the Greater Philadelphia ... experienced cyclists and recreational riders who are passionate about stopping ... affects more than 25 million Americans. , The Tour ... Ambler Campus, located at 580 Meetinghouse Road in Ambler, 30 ...

Breaking Medicine News(10 mins):Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 2 Health News:During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula 3 Health News:Addiction as a disorder of decision-making 2 Health News:COPD May Be Over-Diagnosed Among Uninsured 2 Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2 Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2 Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3

[0] During Celiac Awareness Month, Nutrition Expert Keri Glassman Encourages People with Celiac Disease to Find a Fiber Alternative like Konsyl Original Formula [0] Addiction as a disorder of decision-making [0] COPD May Be Over-Diagnosed Among Uninsured [0] Small increase in cancer risk following CT scans in childhood and adolescence [0] PreDiabetes Centers to Appear at the Philadelphia Tour de Cure

... tripled its customer,base in 2008 and now serves more ... part because of economic uncertainty. Vendormate captures,credentials, and ... chain,interruptions. , "With the global ... anxious about their supply chain," said Andy,Monin, Vendormate president ...

... Bureau Chief Lydia Parnes -PALO ALTO, Calif., Jan. 13 ... of legal services to technology, life sciences, and growth ... the firm as a new partner in March. The ... at the Federal Trade Commission (FTC), Parnes is a ...

... Study will begin recruiting volunteers to take part in its comprehensive study ... a briefing, NIH officials announced that the first phase of recruitment for ... York. , ... Washington, DC (PRWEB) January 13, 2009 ...

... BoxTone(R) Inc., the expert in mobile user management, today announced it ... new purchases of its market-leading software solution to manage, monitor and ... ... January 13, 2009 -- BoxTone(R) Inc., the expert in mobile user ...

... PRINCETON, N.J., Jan. 13 Medarex, Inc. (Nasdaq: ... of the company,s strong science-base and strategy for ... provided were recent highlights of Medarex,s record of ... outlook for product pipeline milestones in 2009, underscoring ...

... lost substantially fewer days of work and worked fewer ... the Feb. 1 issue of Clinical Infectious Diseases ... drug resistance among this year,s flu strains, the study ... The burden of influenza-like illnesses during the flu season ...

Cached Medicine News:Health News:Economic Uncertainty Fuels Vendormate Growth in 2008 2 Health News:Wilson Sonsini Goodrich & Rosati Expands Consumer Regulatory Practice 2 Health News:National Children's Study Begins Recruiting Volunteers 2 Health News:National Children's Study Begins Recruiting Volunteers 3 Health News:National Children's Study Begins Recruiting Volunteers 4 Health News:National Children's Study Begins Recruiting Volunteers 5 Health News:BoxTone Presents Mobile Industry with Timely Money Back Software Guarantee for Managing Enterprise BlackBerry Platform 2 Health News:BoxTone Presents Mobile Industry with Timely Money Back Software Guarantee for Managing Enterprise BlackBerry Platform 3 Health News:BoxTone Presents Mobile Industry with Timely Money Back Software Guarantee for Managing Enterprise BlackBerry Platform 4 Health News:Medarex Reviews Recent Highlights and Outlook for 2009 2 Health News:Medarex Reviews Recent Highlights and Outlook for 2009 3 Health News:Study shows workplace benefits of influenza vaccination in 50-64 year olds 2

Economic Uncertainty Fuels Vendormate Growth in 2008 Wilson Sonsini Goodrich & Rosati Expands Consumer Regulatory Practice National Children's Study Begins Recruiting Volunteers BoxTone Presents Mobile Industry with Timely Money Back Software Guarantee for Managing Enterprise BlackBerry Platform Medarex Reviews Recent Highlights and Outlook for 2009 Study shows workplace benefits of influenza vaccination in 50-64 year olds

Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...

For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl....

Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...

For the quantitative determination of alanine aminotransferase in human serum....

Medicine Products:

GGT Reagent Calcium Reagent Set Calcium Reagent ALT (SGPT) Reagent Set (UV-Kinetic Method)